| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.1M | -34.3% |
| Cost of Revenue | $5.0M | -1.4% |
| Gross Profit | $2.1M | -63.8% |
| R&D Expense | $61.3M | +23.3% |
| SG&A Expense | $25.4M | +3.8% |
| Operating Income | -$84.7M | -23.6% |
| Pre-tax Income | -$216.2M | -7.6% |
| Income Tax | $0 | — |
| Net Income | -$216.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.9M | -33.7% |
| Accounts Receivable | $2.6M | +5.1% |
| Current Assets | $454.8M | +119.9% |
| Total Assets | $666.6M | +134.1% |
| Current Liabilities | $12.2M | +2.4% |
| Total Liabilities | $120.4M | -23.9% |
| Stockholders' Equity | $546.2M | +331.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.5M | -15.6% |
| Capital Expenditures | $18.7M | +68.3% |
| Investing Cash Flow | -$403.3M | -414.7% |
| Financing Cash Flow | $439.1M | +150.2% |
| Free Cash Flow | -$77.2M | -25.1% |
| -7.6% |
| EPS (Basic) | -$0.70 | +35.8% |
| EPS (Diluted) | -$0.70 | +35.8% |